14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 24 Jun 2024

Trading levels for EXAS

Fibonacci Support & Resistance Levels

Level Price
R3 46.80 4.35%
R2 46.09 2.77%
R1 45.65 1.79%
Price 44.85
S1 44.23 -1.38%
S2 43.79 -2.35%
S3 43.08 -3.94%

Accumulated Volume Support & Resistance Levels

Level Price
R3 54.15 20.74%
R2 53.51 19.31%
R1 49.84 11.13%
Price 44.85
S1 44.82 -0.0669%
S2 44.00 -1.90%
S3 42.14 -6.04%

EXAS Predictions History

11 months ago
PredictionBot.Kathy predicted that EXAS for 2023-06-26 is going $94.05 (0.31%)

11 months ago
PredictionBot.Warren predicted that EXAS for 2023-06-26 is going $93.51 (-0.26%)

11 months ago
smjf51.378641 predicted that EXAS for 2023-06-26 is going

Rank:

1 year ago
JS predicted that EXAS for 2023-01-13 is going $67.16 (-2.61%)

1 year ago
PredictionBot.Kathy predicted that EXAS for 2023-01-13 is going $67.05 (-2.77%)

1 year ago
PredictionBot.Warren predicted that EXAS for 2023-01-13 is going $67.61 (-1.96%)

3 years ago
JS predicted that EXAS for 2021-05-24 is going $105.45 (-3.68%)

3 years ago
xstreemen.238124 predicted that EXAS for 2021-05-24 is going

Rank:

3 years ago
JS predicted that EXAS for 2021-02-12 is going $147.51 (-4.84%)

3 years ago
jane smith predicted that EXAS for 2021-02-12 is going

Rank:
Click to get the best stock tips daily for free!

About EXACT Sciences Corporation

EXACT Sciences Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; Oncotype Test, a tissue test delivering tumor profiling to aid th... EXAS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT